一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Side effects of Sparfloxacin

Mar 25,2022

Sparfloxacin (AT-4140, CI-978, PD 131501) is a newer-generation aminodifluoroquinolone with broad spectrum antibacterial activity. It has the chemical formula 5-amino-1-cyclopropyl-7-(cis-3,5-dimethylpiperazin- 1-yl)-6,8-difluoro-1,4-dihydro-4-oxoquinolone-3-carboxylic acid. The main potential advantages of sparfloxacin over older fluoroquinolones are its improved activity against Grampositive pathogens (such as Streptococcus pneumoniae and Staphylococcus aureus), Mycobacteria, and Chlamydophila spp. and its long halflife that allows once-daily dosing. Because of concerns about cardiac risks related to QT interval prolongation and an increased risk of phototoxic reactions, sparfloxacin was withdrawn from the American market in 2001, but it remains available in Japan, India, and parts of Europe as a 200-mg tablet.

Sparfloxacin.png

Bioavailability 

Sparfloxacin is readily absorbed and has oral bioavailability of 92% and a half-life of 16–20 hours.It is 37–45% protein bound. Foods, including milk or high-fat meals, do not significantly alter sparfloxacin absorption.

Excretion

Sparfloxacin is eliminated primarily by nonrenal mechanisms, including hepatic biotransformation, biliary excretion, and possibly transluminal secretion across the enteric mucosa. Sparfloxacin undergoes metabolism to a glucuronide form, which is detectable in plasma at about 30–40% of the unchanged sparfloxacin concentration, and in urine and bile at 2- to 3-fold and 4- to 20-fold the unchanged sparfloxacin concentration, respectively. The glucuronidation pathway is not cytochrome P450 dependent.

Side effects

Sparfloxacin has a similar rate of adverse reactions as ciprofloxacin and other commonly used fluoroquinolones. In a review of six phase III trials in which 1585 patients in the sparfloxacin arms received a 400-mg loading dose followed by 200 mg daily, most common sideeffects were gastrointestinal (such as nausea, diarrhea, dyspepsia, abdominal pain, vomiting, or flatulence; 22.3%), photosensitivity reactions (7.4%), headache (1.9%), insomnia (1.5%), and dizziness (1.1%). QT interval prolongation was seen in 1–3%, but values returned to baseline within 48 hours of drug cessation. The Food and Drug Administration received 145 reports of QT-related cardiac events before sparfloxacin was withdrawn from the American market. 

Experimental modeling shows that sparfloxacin induces greater degrees of QT prolongation than telithromycin, moxifloxacin, or erythromycin. Phototoxic reactions in sparfloxacin recipients have an average onset 6.374.5 days (range, 1–14 days) after commencing the drug. Mostly this consists of erythema on the face and hands, which lasts an average of 6.474.2 days. The hierarchy of phototoxic risk among the fluoroquinolones is lomefloxacin, fleroxacinWsparfloxacinWenoxacinWpefloxacinWciprofloxacin, grepafloxacinWnorfloxacin, ofloxacin, levofloxacin, trovafloxacin, gatifloxacin, moxifloxacin. Photoonycholysis has also been reported with sparfloxacin use.

  • Related articles
  • Related Qustion
See also
4

Aztreonam belongs to the class of beta-lactam antibiotics known as monobactams. Unlike penicillins and cephalosporins the monobactams have only the beta-lactam ring.....

Mar 25,2022API
4

Lomefloxacin (Maxaquins, Pfizer) is an older-generation difluoroquinolone that has the chemical formula 1-ethyl-6,8-difluoro-1,4- dihydro-7-(3-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid. Compared with norfloxacin, it has similar....

Mar 25,2022API

Sparfloxacin

110871-86-8

Sparfloxacin manufacturers

  • Sparfloxacin
  • 110871-86-8 Sparfloxacin
  • $31.00
  • 2026-07-17
  • CAS:110871-86-8
  • Purity: 99.99%
  • Supply Ability: 10g
  • Sparfloxacin
  • 110871-86-8 Sparfloxacin
  • $31.00
  • 2026-07-17
  • CAS:110871-86-8
  • Purity: 99.99%
  • Supply Ability: 10g
  • Sparfloxacin USP/EP/BP
  • 110871-86-8 Sparfloxacin USP/EP/BP
  • $1.10
  • 2025-11-18
  • CAS:110871-86-8
  • Min. Order: 1g
  • Purity: 99.9%
  • Supply Ability: 100 Tons min

桦甸市| 定结县| 北票市| 旬邑县| 普陀区| 东城区| 惠东县| 天柱县| 留坝县| 嘉义市| 连平县| 湛江市| 兴业县| 潼关县| 芜湖市| 淮安市| 准格尔旗| 武城县| 阜宁县| 剑河县| 东光县| 临泽县| 吉安县| 临泽县| 武定县| 张家港市| 寿阳县| 临邑县| 清丰县| 洛南县| 文成县| 北流市| 鄂温| 施甸县| 土默特左旗| 普陀区| 沁源县| 安吉县| 榆树市| 互助| 山东省|